APOB and Sepsis: The anti-inflammatory capacity of apoB-depleted plasma from patients with sepsis was lower than that of the control [VCAM-1 mRNA fold change: 50.1% (39.8–58.1%) vs. 35.5% (28.3–42.7%); p < 0.0001; Fig 1A].